Venture Global, Inc.·4

Mar 9, 6:17 PM ET

Blake Sarah 4

4 · Venture Global, Inc. · Filed Mar 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Venture Global (VG) SVP Sarah Blake Exercises Options, Sells Shares

What Happened

  • Sarah Blake, Senior Vice President and Chief Accounting Officer of Venture Global (VG), exercised stock options and immediately sold the resulting shares. Between March 5 and March 9, 2026 she exercised a total of 330,700 shares (exercise price $1.55 per share) for a cash cost of $512,585 and sold all 330,700 shares in open-market transactions for aggregate gross proceeds of about $3,952,786. Net proceeds before fees and taxes were roughly $3.44M.

Key Details

  • Transaction dates and prices:
    • 2026-03-05: exercised 300,000 shares (two exercises of 150,000) at $1.55; sold those 300,000 for weighted prices reported as $11.57 (150,000 shares; range $11.43–$11.74) and $12.12 / $12.51 (147,100 and 2,900 shares; range $11.50–$12.49 and $12.50–$12.57) — see footnotes F1–F3.
    • 2026-03-09: exercised 30,700 shares at $1.55; sold 30,700 at a weighted $13.00 (range $13.00–$13.02) — footnote F4.
  • Total sold: 330,700 shares; total proceeds ≈ $3.95M; total exercise cost ≈ $512.6K.
  • Shares owned after transaction: not specified in the summary data provided (see the Form 4 for post-transaction holdings).
  • Notable footnotes: sales prices are weighted averages across multiple transactions (F1–F4). The related stock options were adjusted for a prior stock split (F5, F7) and at least one option is fully vested and exercisable (F6).
  • Filing timeliness: trades occurred 2026-03-05 and the Form 4 was filed 2026-03-09. Form 4s are normally due within two business days; this filing appears to have been submitted after that window.

Context

  • This pattern — exercising vested options and promptly selling the shares — is a common cashless exercise/sell-to-cover strategy used by insiders to realize value from equity awards. The filing shows option exercise entries (derivative code M) followed by open-market sales (S). There is no indication in the filing of a 10b5-1 plan or that these were gifts; treat this as routine insider monetization rather than an explicit signal of company direction. For full details (exact per-trade prices, post-trade holdings, and filing timing), consult the SEC Form 4 (Accession 0001720952-26-000002).

Insider Transaction Report

Form 4
Period: 2026-03-05
Blake Sarah
SVP, Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2026-03-05$1.55/sh+150,000$232,500150,000 total
  • Sale

    Class A Common Stock

    [F1]
    2026-03-05$11.57/sh150,000$1,734,9750 total
  • Exercise/Conversion

    Class A Common Stock

    2026-03-05$1.55/sh+150,000$232,500150,000 total
  • Sale

    Class A Common Stock

    [F2]
    2026-03-05$12.12/sh147,100$1,782,3222,900 total
  • Sale

    Class A Common Stock

    [F3]
    2026-03-05$12.51/sh2,900$36,2820 total
  • Exercise/Conversion

    Class A Common Stock

    2026-03-09$1.55/sh+30,700$47,58530,700 total
  • Sale

    Class A Common Stock

    [F4]
    2026-03-09$13.00/sh30,700$399,2070 total
  • Exercise/Conversion

    Stock Options

    [F5][F6]
    2026-03-05300,0008,740,663 total
    Exercise: $1.55Exp: 2030-01-31Class A Common Stock (300,000 underlying)
  • Exercise/Conversion

    Stock Options

    [F5][F6]
    2026-03-0930,7008,709,963 total
    Exercise: $1.55Exp: 2030-01-31Class A Common Stock (30,700 underlying)
Holdings
  • Stock Options

    [F7][F6]
    Exercise: $1.55Exp: 2031-04-20Class A Common Stock
    1,130,082
Footnotes (7)
  • [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.43 to $11.74 per share, inclusive. Upon request by the staff of the Securities and Exchange Commission, the Issuer or any securityholder of the Issuer, the Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $12.49 per share, inclusive. Upon request by the staff of the Securities and Exchange Commission, the Issuer or any securityholder of the Issuer, the Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.57 per share, inclusive. Upon request by the staff of the Securities and Exchange Commission, the Issuer or any securityholder of the Issuer, the Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.02 per share, inclusive. Upon request by the staff of the Securities and Exchange Commission, the Issuer or any securityholder of the Issuer, the Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F5]This stock option was previously reported as covering 2,000 shares of Class A Common Stock at an exercise price of $7,000 per share but was adjusted to reflect the stock split that occurred immediately prior to the consummation of the Issuer's initial public offering (the "Stock Split").
  • [F6]This stock option is fully vested and exercisable.
  • [F7]This stock option was previously reported as covering 250 shares of Class A Common Stock at an exercise price of $7,000 per share but was adjusted to reflect the Stock Split.
Signature
/s /Keith Larson, Attorney-in-Fact for Blake Sarah|2026-03-09

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT